2017
DOI: 10.1016/j.devcel.2017.01.012
|View full text |Cite
|
Sign up to set email alerts
|

Large-Scale Analysis of CRISPR/Cas9 Cell-Cycle Knockouts Reveals the Diversity of p53-Dependent Responses to Cell-Cycle Defects

Abstract: SUMMARY Defining the genes that are essential for cellular proliferation is critical for understanding organismal development and identifying high-value targets for disease therapies. However, the requirements for cell-cycle progression in human cells remain incompletely understood. To elucidate the consequences of acute and chronic elimination of cell-cycle proteins, we generated and characterized inducible CRISPR/Cas9 knockout human cell lines targeting 209 genes involved in diverse cell-cycle processes. We … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

14
200
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
2
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 186 publications
(215 citation statements)
references
References 71 publications
14
200
1
Order By: Relevance
“…Slower NuMA accumulation kinetics after p50 overexpression suggest that dynein-dynactin-NuMA complex formation may aid rapid NuMA recruitment, but dynein 'Walk and Pile-up' alone cannot explain NuMA's minus-end affinity ( Figure 2D,E). To confirm that NuMA localizes to minus-ends even after genetic dynein deletion, we used an inducible CRISPR/Cas9 HeLa cell line to knock out dynein's heavy chain (DHC) (McKinley and Cheeseman, 2017). After dynein knockout (Figure 2-figure supplement 1C,D), both NuMA and dynactin localized robustly to k-fiber minus-ends ( Figure 2F; Figure 2-figure supplement 1E,F).…”
Section: Numa Localizes To Minus-ends Independently Of Dyneinmentioning
confidence: 99%
“…Slower NuMA accumulation kinetics after p50 overexpression suggest that dynein-dynactin-NuMA complex formation may aid rapid NuMA recruitment, but dynein 'Walk and Pile-up' alone cannot explain NuMA's minus-end affinity ( Figure 2D,E). To confirm that NuMA localizes to minus-ends even after genetic dynein deletion, we used an inducible CRISPR/Cas9 HeLa cell line to knock out dynein's heavy chain (DHC) (McKinley and Cheeseman, 2017). After dynein knockout (Figure 2-figure supplement 1C,D), both NuMA and dynactin localized robustly to k-fiber minus-ends ( Figure 2F; Figure 2-figure supplement 1E,F).…”
Section: Numa Localizes To Minus-ends Independently Of Dyneinmentioning
confidence: 99%
“…In contrast, the mutations characterized here disrupt soluble tubulin interactions and microtubule tracking without eliminating binding to the microtubule lattice. To test the effects of these precise mutations on kinetochore function and chromosome segregation, we next utilized an inducible CRISPR/Cas9-based replacement strategy in human HeLa cells [18]. Consistent with prior RNAi-based studies [2, 3, 12, 1923], induction of the Cas9 nuclease in cells constitutively expressing a guide RNA (sgRNA) targeting Ska1 resulted in severe defects in chromosome alignment and mitotic progression that could be rescued by expression of a guide resistant version of GFP-Ska1 (Figure 4A–D; [18]).…”
Section: Resultsmentioning
confidence: 99%
“…We used doxycycline-inducible CRISPR [25] to delete BUB1 in RPE cells with 60% efficiency as judged by IFM, with 42% of cells exiting nocodazole-induced mitotic arrest in less than 800 min ( Fig. S4D-E).…”
Section: Mps1 Phosphorylates the N-terminus Of Rod To Trigger Kinetocmentioning
confidence: 99%
“…Lentiviral transduction was performed as described above. Gene deletion was initiated by inducing a doxycycline-regulated Cas9 transgene present in the host cell line [25] or by infection with AdCas9 (ViraQuest).…”
Section: Aav-mediated Gene Targetingmentioning
confidence: 99%
See 1 more Smart Citation